This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: Five Prime Therapeutics, Inc., Glaxosmithkline Intellectual Property Development Limited. Active years: 2020.
Company Filing History:
1 out of 77 
1 out of 240 
Years Active: 2020
Title: Warren James Rocque: Innovator in Muscle Treatment
Introduction
Warren James Rocque is a notable inventor based in Collegeville, PA (US). He has made significant contributions to the field of medical treatments, particularly focusing on muscle health. His innovative approach has led to the development of a unique patent aimed at addressing muscle wasting and related disorders.
Latest Patents
Warren James Rocque holds a patent for a treatment known as NOPE, which targets pathological muscle loss and weakness. The patent details methods of treating muscle wasting and other disorders using NOPE extracellular domain (ECD) polypeptides and NOPE ECD fusion molecules. This advancement represents a promising avenue for improving muscle health in affected individuals.
Career Highlights
Throughout his career, Rocque has worked with prominent companies in the pharmaceutical and biotechnology sectors. Notably, he has been associated with GlaxoSmithKline Intellectual Property Development Limited and Five Prime Therapeutics, Inc. His experience in these organizations has contributed to his expertise in developing innovative treatments.
Collaborations
Warren James Rocque has collaborated with talented professionals in his field, including Janine Powers and Amy W. Hsu. These partnerships have likely enhanced his research and development efforts, leading to impactful innovations in muscle treatment.
Conclusion
Warren James Rocque's work in developing the NOPE treatment showcases his commitment to advancing medical science and improving patient outcomes. His contributions to the field of muscle health are noteworthy and reflect his dedication as an inventor.